Emerging Treatments  

Researchers are diligently trying to find new types of treatment for advanced prostate cancer and hormone-refractory prostate cancer (cancer that no longer responds to hormonal therapy). Only a few of these new treatments that are studied will ever be approved by the United States Food and Drug Administration (FDA) and ever make it to market. Others will fail in clinical trials or will be found to have side effects that are too toxic.

Ideally new medications that can cure prostate cancer are needed. Until that time, research is being conducted to discover medications that can increase survival times, delay the progression (spread) of the cancer, help to maintain or improve the quality of life of patients, and that have tolerable or no side effects. The most promising research being conducted is in the area of new, so-called “targeted” medications. Targeted medications work by attacking or blocking targets (small proteins or molecules in the body) that are specifically involved in the growth and spread of tumor or cancer cells. Medications of this type have already been developed to treat other common cancers, such as colon and breast cancer. 

Keep up-to-date on all the latest advancements in research and clinical trials through these resources:


Facebook - UsToo.org  Twitter - UsToo.org  LinkedIn - UsToo.org Inspire prostate cancer discussions – UsToo.org 

Contact Us | Privacy Policy | Terms & Conditions | Disclaimer   

Copyright © 2005-2017 Us TOO International, Inc.
Designed and hosted by ACCESS Medical Group, Ltd.